Latest Advances

  • Condition: Myotonic Dystrophy Type 1
  • Journal: Neurology
  • Treatment Used: Mexiletine
  • Number of Patients: 42
  • Published —
The aim of this study was to assess mexiletine's long-term safety and effect on 6-minute walk distance in patients with myotonic dystrophy type 1 (DM1).
  • Condition: Myotonic Dystrophy Type 1
  • Journal: Medicine
  • Treatment Used: Electroacupuncture Therapy
  • Number of Patients: 1
  • Published —
In this case study, researchers evaluated the outcomes of treating myotonic dystrophy type 1 with electroacupuncture therapy.
  • Condition: Myotonic Dystrophy Type 1(DM1)
  • Journal: Journal of neurology
  • Treatment Used: Physical Activity
  • Number of Patients: 106
  • Published —
This study assessed physical activity in patients with myotonic dystrophy type 1 (DM1).
  • Condition: Muscle Disease
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: strength training and aerobic exercise
  • Number of Patients: 428
  • Published —
The purpose of the study was to assess the effects (benefits and harm) of strength training and aerobic exercise training in people with a muscle disease.
  • Condition: Myotonic Dystrophy Type 1 (DM1)
  • Journal: Medicine
  • Treatment Used: Conventional plus Robotic Strength Training
  • Number of Patients: 1
  • Published —
This case-study aimed to demonstrate the effects of a combined approach by using conventional plus robotic training in rare neuromuscular diseases, such as Myotonic dystrophy type 1 (DM1).
  • Condition: Type 1 Myotonic Dystrophy
  • Journal: The American journal of cardiology
  • Treatment Used: Cardiac Resynchronization Therapy
  • Number of Patients: 64
  • Published —
In this study, researchers evaluated the effects of cardiac resynchronization therapy on patients with both type 1 myotonic dystrophy and left bundle branch block.
  • Condition: Myotonic Dystrophy Type 1
  • Journal: Brain : a journal of neurology
  • Treatment Used: Metformin
  • Number of Patients: 40
  • Published —
This study investigated metformin's potential for improving mobility in patients with myotonic dystrophy type 1.
Showing 1-8 of 8